NCDB Analysis of Melanoma 2004-2015: Epidemiology and Outcomes by Subtype, Sociodemographic Factors Impacting Clinical Presentation, and Real-World Survival Benefit of Immunotherapy Approval.

Singh, Sunny R K; Malapati, Sindhu J; Kumar, Rohit; Willner, Christopher; Wang, Ding

Singh, Sunny R K; Malapati, Sindhu J; Kumar, Rohit; Willner, Christopher; Wang, Ding.

Afiliação

Singh SRK; Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI 48202, USA.
Malapati SJ; Department of Hematology and Oncology, Ascension St John Hospital, Detroit, MI 48236, USA.
Kumar R; Department of Hematology and Oncology, University of Louisville, Louisville, KY 40202, USA.
Willner C; Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI 48202, USA.
Wang D; Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI 48202, USA.

Cancers (Basel) ; 13(6)2021 Mar 22.

Article em En | MEDLINE | ID: mdl-33810182

Palavras-chave

epidemiology; healthcare disparities; immune checkpoint inhibitor; immunotherapy; melanoma; real-world data

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article